Retinal pigment epithelium cells generated from iPS cells of allogenic donors, as studied by Healios and Dainippon Sumitomo Pharma could be typed by HLA determination. In collaboration with these companies, Sysmex is exploring alternative tests: ultra-high-sensitivity immunoassays in Sysmex’ HISCL format, and imaging flow cytometry.
Sysmex news release, July 27, 2016
Sysmex develops ultra-high sensitivity immunoassay to detect immune response of allogenic RPE cells before transplantation, cooperation with Healios